Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

13

Revenue 2017

Harvoni

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Harvoni was produced by Bristol-Myers Squibb.

FDA approves Gilead's 'universal' hep C combination Epclusa

FDA approves Gilead's 'universal' hep C combination Epclusa Epclusa joins Sovaldi and Harvoni (sofosbuvir/ledipasvir), a product specifically indicated for patients with hepatitis C virus genotype 1 infection, in Gilead's hep C portfolio. ... Sovaldi and Harvoni brought in sales of $5.3bn and $13.9bn respectively

Deal Watch April 2016

Deal Watch April 2016 In the last 4 years Gilead sales have grown from $8bn to $32bn (CAGR 40%), mainly driven by Sovaldi and Harvoni for hepatitis, resulting in a cash pile of over $20bn.

Gilead, Merck get CHMP backing for new hep C combinations

Gilead, Merck get CHMP backing for new hep C combinations respectively. For Gilead, this is the first regulatory okay for Epclusa, a follow-up to its Sovaldi (sofosbuvir) and Harvoni (sofosbuvir/ledipasvir) products that currently dominate the HCV market with sales

Paywatch and the market access waters

Paywatch and the market access waters Gilead's success with Sovaldi and Harvoni, whose total sales exceed $20bn, shows that a high price does not necessarily prevent market access.

AbbVie hepatitis C combo shows high cure rates

AbbVie hepatitis C combo shows high cure rates Gilead's main product is Harvoni (sofosbuvir/ledipasvir), which made around $10bn in sales last year, and also sells sofosbuvir as a single-agent product (as Sovaldi) that added another ... discount to both Harvoni and Viekirax.

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

Pharma index map
The 2019 CPhI Pharma Index Report
Examining this year’s industry performance...
Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...

Infographics